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Introduction {#sec1}
============

Culture conditions affect features of mouse embryonic stem cells (mESCs), such as their proliferation, gene expression, epigenetic status, self-renewal, and capacity for multi-lineage differentiation ([@bib19], [@bib34]). In culture medium with fetal calf serum, naive mESCs grown on mouse embryonic fibroblast feeder cells (here abbreviated as "serum") transit between inner cell mass (ICM)-like and epiblast-like pluripotency states ([@bib28], [@bib38]). However, when cultured in serum-free conditions with inhibitors of mitogen-activated protein kinase and glycogen synthase kinase 3 signaling, also called "2i" medium, mESCs become more homogeneous and adopt the more ICM-like or "ground" state ([@bib19], [@bib23], [@bib40]). The observation that naive mESCs interconvert between pluripotent states while remaining uncommitted has raised the suggestion that such heterogeneity may allow the cells to respond differently to environmental cues. In agreement, subpopulations of naive mESCs show different potentials to differentiate ([@bib7], [@bib11], [@bib12]). How the metastable transcriptional and epigenetic diversity of cultured mESCs is regulated and maintained has remained elusive.

The two notable characteristics of mESCs are their capacity to self-renew and differentiate into all embryonic lineages ([@bib24]). In mESCs, pluripotency is maintained by a core network of regulatory transcription factors, including *Pou5f1*, *Sox2*, and *Nanog* ([@bib13], [@bib14], [@bib20], [@bib22]); the balance between self-renewal and differentiation is regulated by protein-encoding genes that include *Id1* and *Dusp9*, both downstream targets of the bone morphogenetic protein (BMP) signaling pathway ([@bib18]). Moreover, it has been shown that both the BMP and TGFβ (via NODAL) SMAD-mediated signaling pathways are involved in maintaining heterogeneity of NANOG in naive mESCs ([@bib5]). Conversely, NANOG may attenuate BMP signaling via a feedback loop that involves titration of phosphorylated (P)SMAD1 by direct NANOG-SMAD1 interaction ([@bib32]). However, the functional role of BMP-SMAD signaling in the metastable state of naive pluripotency has not been investigated.

Here, we report the derivation and characterization of transgenic mESCs that allow a real-time readout of SMAD-mediated BMP signaling activity. This transgenic *BRE:gfp* reporter mESC line expresses a well-characterized BMP responsive element (BRE) containing several PSMAD1/5 DNA-binding sites isolated from the *Id1* promoter to drive GFP expression ([@bib16], [@bib21]). Activation of the BMP-SMAD reporter transgene was heterogeneous in serum mESCs (±50% GFP + cells) and 2i mESCs (±4% GFP + cells). By genetic abrogation of the core BMP pathway components SMAD1 and SMAD5, we demonstrated that BMP-SMAD signaling is dispensable for the maintenance and self-renewal of mESCs both in serum and 2i states, but that it regulates the levels of DNA methylation (via *Dnmt3a/b* and *Tet1/2*) and hence lineage priming in pluripotent mESCs.

Results {#sec2}
=======

BMP-SMAD Signaling Is Activated during the Acquisition of Pluripotency {#sec2.1}
----------------------------------------------------------------------

BMP signaling plays key roles in patterning of post-implantation mouse embryos ([@bib15], [@bib33]). However, a role during pre-implantation development has been less evident because genetic ablation of single members of the BMP-SMAD pathway showed no evidence of a phenotype during the pre-implantation period ([@bib6], [@bib8], [@bib26], [@bib41]). We investigated whether the BMP-SMAD signaling pathway was active in pre-implantation embryos by examining *BRE:gfp* blastocysts at E3.5. We were unable to detect GFP at this stage (data not shown). As the BMP-SMAD pathway has been shown to play dual roles in self-renewal and differentiation of mESCs ([@bib18]), we monitored GFP during the derivation of mESCs from *BRE:gfp* blastocysts into the naive state (serum) and the ground state (2i). One day after plating (D1), GFP was still undetectable in blastocysts in either culture condition ([Figure 1](#fig1){ref-type="fig"}A); however, by D4, GFP+ cells were evident within the ICM-like cells of *BRE:gfp* blastocyst outgrowths in both serum and 2i ([Figure 1](#fig1){ref-type="fig"}A). This suggested that the BMP-SMAD pathway was activated during the acquisition of pluripotency in vitro.

BMP-SMAD Signaling Activation in Serum and 2i mESCs {#sec2.2}
---------------------------------------------------

Once *BRE:gfp* mESCs lines had been established ([Figures 1](#fig1){ref-type="fig"}A and 1B) and karyotyped ([Figure S1](#mmc1){ref-type="supplementary-material"}A), a striking difference was observed between the two conditions: serum *BRE:gfp* mESCs exhibited an heterogeneous pattern of GFP expression with about 50% of the cells being GFP+, whereas in 2i *BRE:gfp* mESCs less than 4% of cells were GFP+ ([Figure 1](#fig1){ref-type="fig"}B). In serum *BRE:gfp* mESCs, the GFP+ cells produced ID1 ([Figure 1](#fig1){ref-type="fig"}C), confirming that GFP expression corresponded to the activation of BMP-SMADs. The promoter of *Id1* contains the PSMAD1/5 DNA-binding sites that were used to generate the *BRE:gfp* transgene ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Most 2i *BRE:gfp* mESCs showed no GFP and consequently no/low ID1 ([Figure 1](#fig1){ref-type="fig"}C). POU5F1 and NANOG were detected in both serum and 2i *BRE:gfp* mESCs. Quantification of NANOG suggested that it was more homogeneously expressed in GFP− cells per colony ([Figure 1](#fig1){ref-type="fig"}D) and this difference was statistically significant (n = 16; p \< 0.05).

To measure BMP-SMAD signaling activation, we investigated the levels of PSMAD1/5/8, which were low in 2i medium in serum mESCs and high in 2i after 1 hr of stimulation with 25 ng/ml BMP4; in agreement, faint GFP was observed in 2i compared with serum *BRE:gfp* mESCs ([Figure 1](#fig1){ref-type="fig"}E). In addition, we examined the number of GFP+ cells present in 2i and showed that this increased in response to BMP4 but not to Activin A (which activates the NODAL pathway) ([Figure 1](#fig1){ref-type="fig"}F), and that *BRE:gfp* mESCs could be interconverted to adopt the GFP pattern associated with each culture medium within four cell passages ([Figure 1](#fig1){ref-type="fig"}G).

In Serum, GFP+ *BRE:gfp* mESCs Correlated with Low Levels of *Dnmt3b* and Lower DNA Methylation {#sec2.3}
-----------------------------------------------------------------------------------------------

To further understand the role of BMP-SMAD signaling activation in pluripotency, fluorescence-activated cell sorting (FACS) sorted subpopulations of serum (GFP++, GFP+, GFP−) and 2i (GFP+, GFP−) *BRE:gfp* mESCs ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}A) were analyzed by qPCR ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}B). In serum, the sorted GFP++ mESCs (N = 3) exhibited lower levels of *Dnmt3a/b*, in particular *Dnmt3b*, and higher levels of *Tet1/2*, but similar high transcriptional levels of pluripotency genes ([Figure 2](#fig2){ref-type="fig"}B). A direct comparison between 2i and serum is provided in [Figure S2](#mmc1){ref-type="supplementary-material"}B. Comparing whole transcriptome RNA sequencing (RNAseq) data of three independent serum GFP++ and GFP− mESC samples, we confirmed that *Dnmt3b* as well as *Tet1/2* were among the few statistically significant differentially regulated genes observed (n = 315; p \< 0.05), mostly protein-coding genes ([Figures 2](#fig2){ref-type="fig"}C, [S2](#mmc1){ref-type="supplementary-material"}C, and S2D; [Table S1](#mmc2){ref-type="supplementary-material"}). Next, using available single-cell RNAseq data ([@bib27]), we performed a hierarchical clustering of 38 individual cells from naive mESCs based on the expression of 30 selected genes. Interestingly, the cluster with the lowest transcriptional levels of *Dnmt3b* and high levels of *Tet1* (Group 1) did not correlate with the cell clusters showing high transcriptional levels of *Id1*/*Bmp4* (group 2/3) ([Figure S2](#mmc1){ref-type="supplementary-material"}E). This is in agreement with our qPCR ([Figure 2](#fig2){ref-type="fig"}B) and RNAseq results (*Id1* is not differentially expressed) ([Figure 2](#fig2){ref-type="fig"}C; [Table S1](#mmc2){ref-type="supplementary-material"}) and suggests a clear discrepancy between the cells expressing ID1 protein (and GFP protein) and *Id1* transcript. This discrepancy in the co-expression of proteins and transcripts is a well-known confounding but intrinsic property of cells, including mESCs ([@bib36]).

We performed reduced-representation bisulfite sequencing (RRBS) of GFP++ and GFP− *BRE:gfp* mESCs and observed that DNA methylation levels were in general lower in mESCs with activation of the BMP-SMAD reporter transgene than in mESCs without reporter activity, as illustrated by the significant shifts toward lower DNA methylation at all genomic regions in GFP++ cells ([Figures 2](#fig2){ref-type="fig"}D--2F; [Table S2](#mmc3){ref-type="supplementary-material"}). This is in agreement with the reduced levels of *Dnmt3b* expression in GFP++ cells.

BMP-SMAD Signaling Is Dispensable for Self-Renewal of mESCs {#sec2.4}
-----------------------------------------------------------

To clarify the role of BMP-SMAD signaling in the maintenance of the naive and ground state, we derived *Smad1* and *Smad5* double-knockout (*S1*^*−/−*^*S5*^*−/−*^) mESC lines in 2i from double homozygous floxed *Smad1;Smad5* mESC lines (*S1*^*fl/fl*^*S5*^*fl/fl*^) ([@bib37], [@bib39]) that were hemizygous for the R26R Cre-reporter transgene ([@bib31]) using Cre recombinase ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). We derived the *S1*^*−/−*^*S5*^*−/−*^ mESC in 2i because BMP-SMAD signaling activation was less prominent in 2i and therefore the chance of deriving pluripotent *S1*^−*/−*^*S5*^*−/−*^ mESCs was higher. The pluripotency of the *S1*^*−/−*^*S5*^*−/−*^ mESCs was confirmed by showing its contribution to the three germ layers in *S1*^*−/−*^*S5*^*−/−*^ \<\> wild-type chimeric embryos ([Figure S3](#mmc1){ref-type="supplementary-material"}C), as well as in teratoma formation assays ([Figure S3](#mmc1){ref-type="supplementary-material"}D) in independent lines with a normal karyotype ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Moreover, we showed that *Smad8* was not upregulated in response to the deletion of *Smad1* and *Smad5*, and that *Id1* and *Id2* were upregulated after stimulation with BMP4 only in the *S1*^*fl/fl*^*S5*^*fl/fl*^ parental line, as expected ([Figure S4](#mmc1){ref-type="supplementary-material"}B). The 2i *S1*^*−/−*^*S5*^*−/−*^ mESCs self-renewed at the same rate as the parental *S1*^*fl/fl*^*S5*^*fl/fl*^ mESCs ([Figure 3](#fig3){ref-type="fig"}A) and showed comparable alkaline phosphatase activity ([Figure 3](#fig3){ref-type="fig"}B). Unexpectedly, when *S1*^*−/−*^*S5*^*−/−*^ mESCs were switched from 2i to serum, after an initial period of adaptation the cells continued to self-renew at similar rates as the parental *S1*^*fl/fl*^*S5*^*fl/fl*^ mESCs ([Figure S4](#mmc1){ref-type="supplementary-material"}C) instead of differentiating. In general, the expression level of pluripotency genes remained high in the parental *S1*^*fl/fl*^*S5*^*fl/fl*^ and *S1*^*−/−*^*S5*^*−/−*^ mESCs in 2i ([Figure 3](#fig3){ref-type="fig"}C) and serum ([Figure S4](#mmc1){ref-type="supplementary-material"}D). Our results demonstrated that BMP-SMAD signaling is dispensable for self-renewal of mESCs.

*S1*^*−/−*^*S5*^*−/−*^ mESCs Have High Levels of *Dnmt3b* and High Levels of DNA Methylation {#sec2.5}
--------------------------------------------------------------------------------------------

Next, we investigated the SMAD1/5-responsive genes using RNAseq ([Figure 3](#fig3){ref-type="fig"}D) and found that most differentially expressed genes (DEGs) between *S1*^*−/−*^*S5*^*−/−*^ and *S1*^*fl/fl*^*S5*^*fl/fl*^ mESCs were protein-coding genes ([Figure S4](#mmc1){ref-type="supplementary-material"}E). Interestingly, about half of the DEGs (including protein-coding, pseudogenes, and long non-coding RNAs) were upregulated (n = 781; p \< 0.01) and half of the genes were downregulated (n = 854; p \< 0.01) in *S1*^*−/−*^*S5*^*−/−*^ mESCs ([Figure 3](#fig3){ref-type="fig"}E; [Table S1](#mmc2){ref-type="supplementary-material"}).

To investigate whether the observed expression changes were consistent with direct transcriptional regulation, we integrated our RNAseq dataset with a list of direct SMAD1/5 targets (n = 562) identified by ChIP ([@bib3]). Using gene set enrichment analysis, we found a significant enrichment of SMAD1/5 targets in genes that were downregulated in *S1*^*−/−*^*S5*^*−/−*^ mESCs (p \< 1 × 10^−4^) ([Figure S4](#mmc1){ref-type="supplementary-material"}F).

Moreover, the great majority of the DEGs contained the sequence motifs GCCG and/or GGCGCC, well-characterized SMAD1/5 binding sites ([@bib16]), in their promoters, defined as ±2 kb from the transcriptional start site (TSS) ([Figure 3](#fig3){ref-type="fig"}E; [Table S3](#mmc4){ref-type="supplementary-material"}). By contrast, genome-wide occurrence of GGCGCC and GCCG motifs at such promoters (including protein-coding, pseudogenes, and long non-coding RNAs) was not, or much less, enriched ([Figure S4](#mmc1){ref-type="supplementary-material"}G), and significantly different from the enrichment observed at DEGs (p \< 2.2 × 10^−16^). As an example, *Dnmt3b* was significantly upregulated in *S1*^*−/−*^*S5*^*−/−*^ mESCs and contained 21x GCCG and 5x GGCGCC in the promoter region, suggesting direct (co-)regulation by DNA-binding BMP-SMADs. The DEGs were significantly enriched for gene ontology (GO) categories such as "regulation of developmental process," "regulation of cell development," and "regulation of cell differentiation" ([Figure 3](#fig3){ref-type="fig"}F), compatible with BMP-SMAD signaling not being involved in self-renewal of mESC, but rather predisposing mESCs to differentiate. The downregulation of *Dnmt3b* and enrichment in developmental genes in *S1*^*−/−*^*S5*^*−/−*^ mESCs, led us to investigate the levels of DNA methylation by RRBS on several independent *S1*^*fl/fl*^*S5*^*fl/fl*^ and *S1*^*−/−*^*S5*^*−/−*^ mESC lines ([Table S2](#mmc3){ref-type="supplementary-material"}). *S1*^*−/−*^*S5*^*−/−*^ mESCs displayed a significant shift toward higher levels of DNA methylation at all genomic regions analyzed when compared with *S1*^*fl/fl*^*S5*^*fl/fl*^ mESCs ([Figures 3](#fig3){ref-type="fig"}G--3I), suggesting that the enrichment in developmental genes is caused by the higher levels of DNA methylation.

mESCs Differentiated More Efficiently to Mesendoderm or Neurectoderm in the Absence of BMP-SMAD Signaling {#sec2.6}
---------------------------------------------------------------------------------------------------------

Finally, we examined the differentiation capacity of *S1*^*−/−*^*S5*^*−/−*^ mESCs in both serum and 2i and found that they formed endoderm (*Sox17*), mesoderm (*T*), and ectoderm (*Pax6* and *Sox1*) more efficiently than the parental line ([Figures 4](#fig4){ref-type="fig"}A--4C) in the monolayer using differentiation protocols for either the mesendoderm (ME) or neuroectoderm (NE) lineages ([@bib35]). In addition, we investigated the capacity of the FACS-sorted subpopulations of serum *BRE:gfp* mESCs to differentiate to ME and NE and showed that GFP++ mESCs had lower levels of ME and NE early differentiation markers than GFP− mESCs ([Figure 4](#fig4){ref-type="fig"}D), demonstrating that GFP++ mESCs were less prone to differentiate. In agreement, GFP++ mESCs retained higher levels of pluripotency markers, at least after 4 days of differentiation to ME ([Figure 4](#fig4){ref-type="fig"}E). Our data showed that transient BMP-SMAD signaling activation tilted mESCs to a less differentiation-prone state, whereas in the absence of BMP-SMAD signaling the balance was shifted toward an increased predisposition to differentiate.

Discussion {#sec3}
==========

A recent study reported the absence of *Bmp4* and *Id1* in (embryonic day) E3.5 ICMs and a high transient upregulation in E4.5 epiblasts, followed by downregulation of *Bmp4* and *Id3* expression during the next 6 days of the derivation of mESCs and their further maintenance in 2i ([@bib1]). We now show this in real-time using *BRE:gfp* blastocysts to derive mESCs. Moreover, we demonstrated that BMP-SMAD signaling is not functionally implicated in self-renewal, in agreement with studies that have mapped genome-wide the genes that are directly regulated by SMAD1/5 ([@bib2], [@bib3]). They showed that the genes regulated by SMAD1/5 were involved in fate determination, rather than self-renewal. Here, we provide functional evidence that SMAD1/5 are not necessary for mESC self-renewal in either naive (serum) or ground (2i) state.

Specific levels of DNA methylation and associated enzymes have been associated with the different pluripotency states (ground, naive, primed) ([@bib9], [@bib10], [@bib29]), as well as with different levels of GFP in *Nanog:gfp* naive mESCs ([@bib4]). This reflects faithfully the rapid loss of genomic DNA methylation that the embryo undergoes in vivo during pre-implantation development, and the gain of DNA methylation during the transition between ICM and epiblast ([@bib30]). Therefore, it is perhaps not surprising that the machinery to regulate rapid switches in genomic DNA methylation is present in pluripotent stem cells derived from ICM and epiblast. A role for BMP-SMAD signaling in LIF-dependent conversion between EpiSCs and ESCs has been reported ([@bib25]), but the association with changes in DNA methylation between EpiSCs and ESCs remains to be investigated.

Finally, it has been suggested that the epigenetic variation observed in pluripotent cells is stochastic and results in a diversity of predispositions to acquire specific cell fates when the cells are triggered to differentiate ([@bib17]). Our data provide evidence that the cellular diversity of both serum and 2i mESCs regarding DNA methylation and associated enzymes is not a stochastic process as previously thought, but is in fact regulated by cell-cell signaling interactions involving the BMP-SMAD signaling pathway.

Experimental Procedures {#sec4}
=======================

mESCs Derivation and Culture {#sec4.1}
----------------------------

Derivation of *BRE:gfp* mESCs in 2i and serum and the conditional knockout mESCs for *Smad1* and *Smad5* (*S1*^*fl/fl*^*S5*^*fl/fl*^) in 2i, as well as the Cre-recombination of *S1*^*fl/fl*^*S5*^*fl/fl*^ mESCs, are described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Genotyping of the *BRE:gfp* mESCs was performed as described ([@bib21]). E14 mESCs were cultured in either 2i or serum. Stimulation (1 hr) with BMP4 (R&D Systems) or Activin A (R&D Systems) was followed by FACS analysis or western blotting (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). Details about generation of chimeric embryos, the teratoma formation assay, RNAseq, and RRBS are provided in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

mESCs Differentiation and Proliferation {#sec4.2}
---------------------------------------

mESCs were differentiated to ME or NE as described ([@bib35]). Briefly, mESCs (10,000 cells/cm^2^) were grown in N2B27 medium without supplements for 48 hr, after which either 3 μM CHIR99021 or 500 nM all-*trans* retinoic acid (RA) (Sigma-Aldrich) was added to the N2B27 medium for an additional 48 hr. Cells were then collected for immunofluorescence or qPCR (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). For the proliferation assay, the total number of serum and 2i mESCs was monitored during each passage for 26 days of culture. Serum mESCs were pre-plated prior to counting.

Statistics {#sec4.3}
----------

### Quantification of NANOG-Positive Cells {#sec4.3.1}

Whole *BRE:gf*p mESC colonies (total n = 16) from three independent experiments (N = 3, 5--6 colonies per experiment) were manually counted three times and averaged. N refers to the number of independent experiments; n refers to total number or colonies counted. Statistical analysis was performed using the Student t-test (two-tailed, unequal variance), ^∗^p ≤ 0.05.

### qPCR {#sec4.3.2}

In qPCR, each bar represents the average of technical triplicates. N refers to the number of independent experiments; n refers to total replicates. Statistical analysis was performed using the Student t-test (two-tailed, unequal variance), ^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01.

### RNAseq Expression Data {#sec4.3.3}

To determine significantly DEGs between GFP++ and GFP− or S1^−/−^S5^−/−^ and ^S1fl/fl^S5^fl/fl^ mESCs, we applied a cut-off of 0.01 and/or 0.05 on the p values adjusted for multiple testing hypothesis. N refers to the number of independent experiments; n refers to the number of genes.

### RNAseq GO {#sec4.3.4}

Enrichment analysis for GO terms was done with the R package topGO based on DEGs (p \< 0.05) and utilizing Fisher's exact test.

### RNAseq Motif Sequence Analysis {#sec4.3.5}

One-sided Fisher's exact was used to determine significant over-representation of the analyzed motifs in promoter regions of DEGs relative to the genome-wide promoter regions. n refers to the number of genes.

### SMAD1/5 ChIP-on-chip Data {#sec4.3.6}

To calculate the enrichment of SMAD1/5 targets identified p values were calculated by permuting genes. n refers to the number of genes.

### RRBS Global Methylation Profile {#sec4.3.7}

To quantitatively assess global DNA methylation changes, we created histograms for tiles (methylation change \>20%) and performed a one-sided two-sample Kolmogorov-Smirnov test to determine significant distribution differences between populations.
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![BMP-SMAD Signaling Activation in Serum and 2i Culture Conditions\
(A) Derivation of *BRE:gfp* mESCs in serum and 2i conditions. D1, 1 day after blastocyst collection; D4, D1 plus 3 days after blastocyst plating, P3 mESCs, passage 3 of the derived mESCs. Scale bars represent 100 μm.\
(B) Established serum and 2i *BRE:gfp* mESCs and their respective GFP expression profiles by FACS analysis. Scale bars represent 100 μm.\
(C) Immunofluorescence of serum and 2i *BRE:gfp* mESCs for ID1, POU5F1, and NANOG. Scale bars represent 20 μm.\
(D) Percentage (%) of NANOG-positive cells in the GFP+ and GFP− cells per colony *BRE:gfp* mESCs.\
(E) Western blotting for PSMAD1/5/8, SMAD1/5/8, GFP and Tubulin in serum and 2i *BRE:gfp* and E14 mESCs as well as 2i E14 stimulated 1 hr with 25 ng/ml BMP4.\
(F) Percentage (%) of GFP+ and GFP− cells in 2i *BRE:gfp* mESCs after 1 hr treatment with Activin A or BMP4. Bars represent the mean ± SD (N = 3).\
(G) Percentage (%) of GFP+ and GFP− cells in 2i *BRE:gfp* mESCs switched to serum and serum *BRE:gfp* mESCs switched to 2i and cultured for four consecutive passages (P1--P4). See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Transcriptome and Methylome in Subsets of Serum *BRE:gfp* mESCs\
(A) Gatings used to FACS sort three subpopulations (GFP−, GFP+, GFP++) of serum *BRE:gfp* mESCs and the profile of the individual cell groups.\
(B) Relative expression of several genes in the three subpopulations (GFP−, GFP+, GFP++) of serum *BRE:gfp* mESCs compared with the GFP− cells. Each bar represents the mean ± SD of technical triplicates and the three bars of the same color represent independent experiments (n = 9, N = 3).\
(C) Volcano plot showing --log10 p values versus log2 fold transcriptional changes between GFP++ and GFP− fractions of serum *BRE:gfp* mESCs. Differentially expressed genes (DEGs) with p \< 0.05 are blue, and genes with p \> 0.05 are red; some highlighted DEGs are black.\
(D) Scatterplot depicting a comparison of the percentage of DNA methylation in each 600-bp tile (dot) between GFP++ and GFP− fractions of serum *BRE:gfp* mESCs. Each tile was classified into a biotype category according to the nearest TSS. The red line represents no difference; the inner and outer blue lines represent borders for 10% and 20% change in methylation levels, respectively.\
(E) Distribution of DNA methylation at specific genomic regions in GFP++ (in blue) and GFP− fractions of serum *BRE:gfp* (in red) mESCs. p Values were calculated with the two-sample Kolmogorov-Smirnov test. HCP, high CpG-content promoters; LCP, low CpG-content promoters; Enh, enhancers; NA, no annotation.\
(F) Number of (600-bp tile) counts showing loss of methylation (LOM) or gain of methylation (GOM) in GFP++ compared with GFP− serum *BRE:gfp* mESC. See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc5){ref-type="supplementary-material"}.](gr2){#fig2}

![Transcriptome and Methylome in *S1*^*−/−*^*S5*^*−/−*^ versus *S1*^*fl/fl*^*S5*^*fl/fl*^ mESCs\
(A) Growth of *S1*^*fl/fl*^*S5*^*fl/fl*^ mESCs and three independent *S1*^*−/−*^*S5*^*−/−*^ mESCs lines in 2i during 26 days. Means ± SD are depicted.\
(B) Alkaline phosphatase activity in 2i *S1*^*fl/fl*^*S5*^*fl/fl*^ and *S1*^*−/−*^*S5*^*−/−*^ mESC. Scale bars represent 100 μm.\
(C) Expression of *Sox2*, *Zfp42*, *Nanog*, and *Pou5f1* in transcripts per million (TPM) in 2i *S1*^*fl/fl*^*S5*^*fl/fl*^ (FL) and *S1*^*−/−*^*S5*^*−/−*^ (KO) mESC.\
(D) Volcano plot showing --log10 p values versus log2 fold transcriptional changes between *S1*^*fl/fl*^*S5*^*fl/fl*^ and *S1*^*−/−*^*S5*^*−/−*^ mESCs in 2i. DEGs with p \< 0.05 are blue, and genes with p \> 0.05 are red; some highlighted DEGs are black.\
(E) Percentage of DEGs (p \< 0.01) (n = 781 upregulated in 2i *S1*^*−/−*^*S5*^*−/−*^; n = 854 downregulated in 2i *S1*^*−/−*^*S5*^*−/−*^) showing putative SMAD1/5 binding sites (GGCGCC/GCCG) in the promoter region.\
(F) Top ten GO terms associated with biological processes (p \< 0.05) in DEGs in 2i *S1*^*−/−*^*S5*^*−/−*^ mESCs.\
(G) Distribution of DNA methylation levels at specific genomic regions in 2i *S1*^*fl/fl*^*S5*^*fl/fl*^ (in red) and *S1*^*−/−*^*S5*^*−/−*^ mESCs (in blue). p Values were calculated with two-sample Kolmogorov-Smirnov test. HCP, high CpG-content promoters; LCP, low CpG-content promoters; Enh, enhancers; NA, no annotation.\
(H) Number of (600-bp tile) counts showing LOM or GOM in 2i *S1*^*fl/fl*^*S5*^*fl/fl*^ compared with *S1*^*−/−*^*S5*^*−/−*^ mESCs.\
(I) Scatterplot depicting a comparison of the percentage of DNA methylation in each 600-bp tile (dot) between 2i *S1*^*fl/fl*^*S5*^*fl/fl*^ and *S1*^*−/−*^*S5*^*−/−*^ mESCs. Each tile was classified into a biotype category according to the nearest TSS. The red line represents no difference, and the inner and outer blue lines represent borders for 10% and 20% change in methylation levels, respectively. See also [Figures S3](#mmc1){ref-type="supplementary-material"}, [S4](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, and [S3](#mmc4){ref-type="supplementary-material"}.](gr3){#fig3}

![BMP-SMAD Signaling during mESC Differentiation to Mesendoderm and Neurectoderm\
(A) Schematic representation of the protocol to differentiate mESCs to mesendoderm (3 μM CHIR) or neurectoderm (500 nM retinoic acid \[RA\]).\
(B) Relative expression of early lineage markers in differentiated serum and 2i *S1*^*−/−*^*S5*^*−/−*^ and *S1*^*fl/fl*^*S5*^*fl/fl*^ mESCs.\
(C) Immunofluorescence of differentiated serum *S1*^*fl/fl*^*S5*^*fl/fl*^ and *S1*^*−/−*^*S5*^*−/−*^ mESCs for NANOG, SOX17, T, and SOX1. Scale bars represent 100 μm.\
(D) Relative expression of early lineage markers in differentiated subpopulations (GFP−, GFP+, GFP++) of serum *BRE:gfp* mESCs compared with GFP− cells.\
(E) Relative expression of pluripotency genes in differentiated subpopulations (GFP−, GFP+, GFP++) of serum *BRE:gfp* mESCs compared with GFP− cells.\
Each bar represents the mean ± SD of technical triplicates and bars of the same color represent independent experiments (n = 9, N = 3) in (B) and independent experiments (n = 6, N = =2) in (D) and (E). Statistical analysis was performed on technical triplicates of independent experiments (n = 9, N = 3), ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01.](gr4){#fig4}
